A detailed history of Bayesian Capital Management, LP transactions in Entegris Inc stock. As of the latest transaction made, Bayesian Capital Management, LP holds 16,000 shares of ENTG stock, worth $1.69 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
16,000
Holding current value
$1.69 Million
% of portfolio
0.21%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$98.09 - $146.48 $1.57 Million - $2.34 Million
16,000 New
16,000 $1.8 Million
Q3 2021

Nov 15, 2021

SELL
$111.63 - $134.83 $379,542 - $458,422
-3,400 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$101.61 - $123.26 $199,968 - $242,575
-1,968 Reduced 36.66%
3,400 $418,000
Q1 2021

May 14, 2021

BUY
$93.99 - $113.56 $250,765 - $302,978
2,668 Added 98.81%
5,368 $600,000
Q4 2020

Feb 12, 2021

BUY
$74.72 - $99.03 $201,744 - $267,381
2,700 New
2,700 $259,000

Others Institutions Holding ENTG

About ENTEGRIS INC


  • Ticker ENTG
  • Exchange NASDAQ
  • Sector Technology
  • Industry Semiconductor Equipment & Materials
  • Shares Outstandng 148,964,000
  • Market Cap $15.7B
  • Description
  • Entegris, Inc. develops, manufactures, and supplies microcontamination control products, specialty chemicals, and advanced materials handling solutions in North America, Taiwan, China, South Korea, Japan, Europe, and Southeast Asia. It operates in three segments: Specialty Chemicals and Engineered Materials (SCEM); Microcontamination Control (MC...
More about ENTG
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.